直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

IWPCPS-10

June 8-14, 2008

Bamberg, Germany

Advanced Solid State Analysis International

Advanced Solid State Analysis organizes international workshops and programs on modern physical characterization to the pharmaceutical community. Finnegan attorney Mark Feldstein will present "Applying lessons from litigation to defining the pharmaceutical invention" at the Tenth International Workshop on Physical Characterization of Pharmaceutical Solids. The conference will take place at the Hotel Residenzschloss in Bamberg, Germany. For more information, or to register, please see ASSA's website.

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Professionals

Mark J. Feldstein, Ph.D.
Partner
Washington, DC
+1 202 408 4092
Email

Related Insights

Articles

EPR Academy, Part 5 of 6: Special Considerations for Third-Party Requesters

October 14, 2026

Federal Circuit IP Blog

Private Sale Gets No Safe Harbor from §102(b)(1)(B)

October 14, 2026

Articles

Who Is a “Consumer?” The Supreme Court Takes Up the Video Privacy Protection Act

October 12, 2026

Articles

California Court Considers CIPA’s Application to Online Tracking as New Law Limits Private Actions

October 7, 2026

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: August 2026

September 29, 2026

Articles

California Brings First CCPA and Delete Act Enforcement Action Against Data Broker

September 4, 2026

Articles

Beyond Hikma: Patent Prosecution Strategies  for Anticipating Skinny-Label Generics  in Pharmaceutical Patent Portfolios

September 2026

IP Updates

Too Concrete to Fail: Ceiva’s Guidance on the Use of Sufficiently Concrete Structures to Overcome Section 101 Rejections

July 28, 2026

Articles

This Article Was Written Entirely by AI — Welcome to Synthetic Patent Litigation

July/August 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP